Open Access

Cytoprotective effects of silafibrate, a newly-synthesised siliconated derivative of clofibrate, against acetaminophen-induced toxicity in isolated rat hepatocytes


1. Amar PJ, Schiff ER. Acetaminophen safety and hepatotoxicity - where do we go from here? Expert Opin Drug Saf 2007;6:341-55. doi: 10.1517/14740338.6.4.34110.1517/14740338.6.4.341Search in Google Scholar

2. Dai G, He L, Chou N, Wan YJ. Acetaminophen metabolism does not contribute to gender difference in its hepatotoxicity in mouse. Toxicol Sci 2006;92:33-41. doi: 10.1093/toxsci/ kfj192Search in Google Scholar

3. James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 2003;31:1499-506. doi: 10.1124/dmd.31.12.149910.1124/dmd.31.12.1499Search in Google Scholar

4. Hinson JA, Nelson SD, Mitchell JR. Studies on the microsomal formation of arylating metabolites of acetaminophen and phenacetin. Mol Pharmacol 1977;13:625-33. PMID: 18660Search in Google Scholar

5. Bruno M. Inhibition of protein phosphatase activity and changes in protein phosphorylation following acetaminophen exposure in cultured mouse hepatocytes. Toxicol Appl Pharmacol 1998;153:119-32. PMID: 987530610.1006/taap.1998.8512Search in Google Scholar

6. Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schiødt FV, Ostapowicz G, Shakil AO, Lee WM. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42:1364-72. doi: 10.1002/hep.2094810.1002/hep.20948Search in Google Scholar

7. Schilling A, Corey R, Leonard M, Eghtesad B. Acetaminophen: Old drug, new warnings. Cleve Clin J Med 2010;77:19-27. doi: 10.3949/ccjm.77a.0908410.3949/ccjm.77a.09084Search in Google Scholar

8. Ziaee M, Samini M, Bolourtchian M, Ghaffarzadeh M, Ahmadi M, Eghbal MA, Khorrami A, Andalib S, Maleki- Dizaji N, Garjani A. Synthesis of a novel siliconized analog of clofibrate (Silafibrate) and comparison of their antiinflammatory activities. Iran J Pharm Res 2011;11:91-5.Search in Google Scholar

9. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Anti-inflammatory effects of fibrates: an overview. Current M e d C h e m 2 0 0 9 ; 1 6 : 6 7 6 - 8 4 . d o i : 10.2174/092986709787458416Search in Google Scholar

10. Toyama T, Nakamura H, Harano Y, Yamauchi N, Morita A, Kirishima T, Minami M, Itoh Y, Okanoue T. PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun 2004;324:697-704. PMID: 1547448410.1016/j.bbrc.2004.09.110Search in Google Scholar

11. Dyrøy E, Røst TH, Pettersen RJ, Halvorsen B, Gudbrandsen OA, Ueland T, Muna Z, Müller F, Nordrehaug JE, Aukrust P, Berge RK. Tetradecylselenoacetic acid, a PPAR ligand with antioxidant, antiinflammatory, and hypolipidemic properties. Arterioscler Thromb Vasc Biol 2007;27:628-34. doi: 10.1161/01.ATV.0000255950.70774.d510.1161/01.ATV.0000255950.70774.d5Search in Google Scholar

12. Chen C, Hennig GE, Whiteley HE, Corton JC, Manautou JE. Peroxisome proliferator-activated receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure. Toxicol Sci 2000;57:338-44. PMID: 1100636310.1093/toxsci/57.2.338Search in Google Scholar

13. Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack BH. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991;20:1058-63. PMID: 192887410.1016/S0196-0644(05)81352-6Search in Google Scholar

14. Heidari R, Babaei H, Eghbal MA. Ameliorative effects of taurine against methimazole-induced cytotoxicity in isolated rat hepatocytes. Sci Pharm 2012;80:987-99. doi: 10.3797/ scipharm.1205-1610.3797/scipharm.1205-16352805723264945Search in Google Scholar

15. Moldéus P, Högberg J, Orrenius S. Isolation and use of liver cells. Methods Enzymol 1978;52:60-71. PMID: 67265610.1016/S0076-6879(78)52006-5Search in Google Scholar

16. Elbarbry FA, McNamara PJ, Alcorn J. Ontogeny of hepatic CYP1A2 and CYP2E1 expression in rat. J Biochem Mol Toxicol 2007;21:41-50. doi: 10.1002/jbt.2015610.1002/jbt.2015617366540Search in Google Scholar

17. Heidari R, Babaei H, Roshangar L, Eghbal MA. Effects of enzyme induction and/or glutathione depletion on methimazole-induced hepatotoxicity in mice and the protective role of N-acetylcysteine. Adv Pharm Bull 2014;4:21-8. doi: 10.5681/apb.2014.004Search in Google Scholar

18. Bayne K. Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society. Physiologist 1996;39:199, 208-11. PMID: 8854724Search in Google Scholar

19. Truong DH, Eghbal MA, Hindmarsh W, Roth SH, O’Brien PJ. Molecular mechanisms of hydrogen sulfide toxicity. Drug Metab Rev 2006;38:733-44. PMID: 1714569810.1080/0360253060095960717145698Search in Google Scholar

20. Martin JW, Chan K, Mabury SA, O’Brien PJ. Bioactivation of fluorotelomer alcohols in isolated rat hepatocytes. Chem Biol Interact 2009;177:196-203. doi: 10.1016/j. cbi.2008.11.001Search in Google Scholar

21. Eghbal MA, Pennefather PS, O’Brien PJ. H2S cytotoxicity mechanism involves reactive oxygen species formation and mitochondrial depolarisation. Toxicology 2004;203:69-76. PMID: 1536358310.1016/j.tox.2004.05.02015363583Search in Google Scholar

22. Heidari R, Babaei H, Eghbal M. Mechanisms of methimazole cytotoxicity in isolated rat hepatocytes. Drug Chem Toxicol 2013;36:403-11. doi: 10.3109/01480545.2012.74927210.3109/01480545.2012.74927223256569Search in Google Scholar

23. Mehta R, Wong L, O’Brien PJ. Cytoprotective mechanisms of carbonyl scavenging drugs in isolated rat hepatocytes. Chem Biol Interact 2009;178:317-23. doi: 10.1016/j. cbi.2008.10.026Search in Google Scholar

24. Banach MS, Dong Q, O’Brien PJ. Hepatocyte cytotoxicity induced by hydroperoxide (oxidative stress model) or glyoxal (carbonylation model): prevention by bioactive nut extracts or catechins. Chem Biol Interact 2009;178:324-31. doi: 10.1016/j.cbi.2008.10.00310.1016/j.cbi.2008.10.00318983988Search in Google Scholar

25. Feng CY, Wong S, Dong Q, Bruce J, Mehta R, Bruce WR, O’Brien PJ. Hepatocyte inflammation model for cytotoxicity research: fructose or glycolaldehyde as a source of endogenous toxins. Arch Physiol Biochem 2009;115:105-11. doi: 10.1080/1381345090288705510.1080/1381345090288705519485706Search in Google Scholar

26. Niknahad H, O’Brien PJ. Mechanism of sulfite cytotoxicity in isolated rat hepatocytes. Chem Biol Interac 2008;174:147-54. doi: 10.1016/j.cbi.2008.05.03210.1016/j.cbi.2008.05.03218579106Search in Google Scholar

27. Heidari R, Babaei H, Eghbal MA. Amodiaquine-induced toxicity in isolated rat hepatocytes and the cytoprotective effects of taurine and/or N-acetyl cysteine. Res Pharm Sci 2014;9:97-105.Search in Google Scholar

28. Abdoli N, Heidari R, Azarmi Y, Eghbal MA. Mechanisms of the statins cytotoxicity in freshly isolated rat hepatocytes. J Biochem Mol Toxicol 2013;27:287-94. doi: 10.1002/ jbt.2148510.1002/jbt.2148523761184Search in Google Scholar

29. Heidari R, Babaei H, Eghbal MA. Cytoprotective effects of organosulfur compounds against methimazole-induced toxicity in isolated rat hepatocytes. Adv Pharm Bull 2013;3:135-42. doi: 10.5681/apb.2013.023Search in Google Scholar

30. Heidari R, Babaei H, Eghbal MA. Cytoprotective effects of taurine against toxicity induced by isoniazid and hydrazine in isolated rat hepatocytes. Arh Hig Rada Toksikol 2013;64:201-9. doi: 10.2478/10004-1254-64-2013-229710.2478/10004-1254-64-2013-229723819928Search in Google Scholar

31. Manautou JE, Hoivik DJ, Tveit A, Hart SGE, Khairallah EA, Cohen SD. Clofibrate pretreatment diminishes acetaminophen′s selective covalent binding and hepatotoxicity. Toxicol Appl Pharmacol 1994;129:252-63. PMID: 799231510.1006/taap.1994.1250Search in Google Scholar

32. Chen C, Hennig GE, Whiteley HE, Corton JC, Manautou JE. Peroxisome proliferator-activated receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure. Toxicol Sci 2000;57:338-44. PMID: 1100636310.1093/toxsci/57.2.338Search in Google Scholar

33. Nicholls-Grzemski FA, Calder IC, Priestly BG, Burcham PC. Clofibrate-induced in vitro hepatoprotection against acetaminophen is not due to altered glutathione homeostasis. Toxicol Sci 2000;56:220-8. doi: 10.1093/toxsci/56.1.22010.1093/toxsci/56.1.220Search in Google Scholar

34. Chen C, Hennig GE, Whiteley HE, Manautou JE. Protection against acetaminophen hepatotoxicity by clofibrate pretreatment: role of catalase induction. J Biochem Mol Toxicol 2002;16:227-34. PMID: 1243986410.1002/jbt.10043Search in Google Scholar

35. Antonenkov VD, Gusev VA, Panchenko LF. Effect of clofibrate treatment on glutathione content and the activity of the enzymes related to peroxide metabolism in rat liver and heart. Int J Biochem 1987;19:187-92. doi: 10.1016/0020-711X(87)90330-210.1016/0020-711X(87)90330-2Search in Google Scholar

36. Camps J, García-Heredia A, Rull A, Alonso-Villaverde C, Aragonès G, Beltrán-Debón R, Rodríguez-Gallego E, Joven J. PPARs in regulation of paraoxonases: control of oxidative stress and inflammation pathways. PPAR Research 2012;2012:616371. doi: 10.1155/2012/61637110.1155/2012/616371327046622315585Search in Google Scholar

37. Gelosa P, Banfi C, Gianella A, Brioschi M, Pignieri A, Nobili E, Castiglioni L, Cimino M, Tremoli E, Sironi L. Peroxisome proliferator-activated receptor α agonism prevents the oxidative stress and inflammatory processes involved in brain and renal damage in stroke-prone rats. J Pharmacol Exp Therap 2010;335:324-31. doi: 10.1124/jpet.110.17109010.1124/jpet.110.17109020671072Search in Google Scholar

38. Devchand PR, Ziouzenkova O, Plutzky J. Oxidative stress and peroxisome proliferator-activated receptors reversing the curse? Circ Res 2004;95:1137-9. doi: 10.1161/01. RES.0000151331.69399.b2Search in Google Scholar

39. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, Bonacchi A, Caporale R, Laffi G, Pinzani M, Gentilini P. Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000;119:466-78. PMID: 1093038210.1053/gast.2000.936510930382Search in Google Scholar

40. Fruchart JC, Bastide M. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem SocTrans 2006;34:1341-6. PMID: 1707381510.1042/BST034134117073815Search in Google Scholar

41. Hwang J, Kleinhenz DJ, Lassègue B, Griendling KK, Dikalov S, Hart CM. Peroxisome proliferator-activated receptor-γ ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 2005;288:C899-905. PMID: 1559089710.1152/ajpcell.00474.200415590897Search in Google Scholar

42. Bebarta VS, Kao L, Froberg B, Clark RF, Lavonas E, Qi M, Delgado J, McDonagh J, Arnold T, Odujebe O, O’Malley G, Lares C, Aguilera E, Dart R, Heard K, Stanford C, Kokko J, Bogdan G, Mendoza C, Mlynarchek S, Rhyee S, Hoppe J, Haur W, Tan HH, Tran NN, Varney S, Zosel A, Buchanan J, Al-Helial M. A multicenter comparison of the safety of oral versus intravenous acetylcysteine for treatment of acetaminophen overdose. Clin Toxicol 2010;48:424-30. doi: 10.3109/15563650.2010.48638110.3109/15563650.2010.486381Search in Google Scholar

43. Reid AB, Kurten RC, McCullough SS, Brock RW, Hinson JA. Mechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. J Pharmacol Exp Therap 2005;312:509-16. doi: 10.1124/jpet.104.07594510.1124/jpet.104.075945Search in Google Scholar

44. Jones AL. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning a critical review. J Toxicol Clin Toxicol 1998;36:277-85. PMID: 971119210.3109/15563659809028022Search in Google Scholar

45. Rodrigues GA, Maurier-Mahé F, Shurland D-L, McLaughlin A, Luhrs K, Throo E, Delalonde-Delaunay L, Pallares D, Schweighoffer F, Donello J. Differential effects of PPARgamma ligands on oxidative stress-induced death of retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 2011;52:890-903. doi: 10.1167/iovs.10-571510.1167/iovs.10-5715Search in Google Scholar

46. Blokhina O, Virolainen E, Fagerstedt KV. Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann Botany 2003;91:179-94. doi: 10.1093/aob/mcf11810.1093/aob/mcf118Search in Google Scholar

47. Kowaltowski AJ, Vercesi AE. Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 1999;26:463-71. PMID: 9895239 10.1016/S0891-5849(98)00216-0Search in Google Scholar

English, Slovenian
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Basic Medical Science, other